Bank Of New York Mellon Corp 89bio, Inc. Transaction History
Bank Of New York Mellon Corp
- $521 Trillion
- Q1 2024
A detailed history of Bank Of New York Mellon Corp transactions in 89bio, Inc. stock. As of the latest transaction made, Bank Of New York Mellon Corp holds 248,746 shares of ETNB stock, worth $1.97 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
248,746
Previous 222,420
11.84%
Holding current value
$1.97 Million
Previous $2.48 Billion
16.54%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ETNB
# of Institutions
165Shares Held
89.1MCall Options Held
584KPut Options Held
1.17M-
Janus Henderson Group PLC London, X012.6MShares$99.6 Million0.08% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$58.3 Million1.38% of portfolio
-
Black Rock Inc. New York, NY6.64MShares$52.4 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.3MShares$49.8 Million3.14% of portfolio
-
State Street Corp Boston, MA5.54MShares$43.8 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $367M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...